ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,301,026 | -7.0% | 388,379 | -1.8% | 1.04% | -2.6% |
| Q2 2023 | $28,291,621 | +1.4% | 395,300 | -1.6% | 1.07% | -2.9% |
| Q1 2023 | $27,892,756 | -1.4% | 401,855 | -3.7% | 1.10% | -16.2% |
| Q4 2022 | $28,278,160 | +22.8% | 417,082 | -0.7% | 1.32% | +8.9% |
| Q3 2022 | $23,027,000 | -28.9% | 419,888 | -14.3% | 1.21% | -22.5% |
| Q2 2022 | $32,386,000 | -11.7% | 490,173 | -11.3% | 1.56% | +5.5% |
| Q1 2022 | $36,662,000 | +7.7% | 552,637 | -5.4% | 1.48% | +9.9% |
| Q4 2021 | $34,046,000 | -4.9% | 584,479 | -1.9% | 1.35% | -10.7% |
| Q3 2021 | $35,795,000 | +0.5% | 595,995 | +0.2% | 1.51% | -0.3% |
| Q2 2021 | $35,631,000 | +18.6% | 594,838 | -1.6% | 1.51% | +11.7% |
| Q1 2021 | $30,052,000 | -1.0% | 604,425 | -0.5% | 1.35% | -9.7% |
| Q4 2020 | $30,358,000 | -10.6% | 607,278 | -2.0% | 1.50% | -20.4% |
| Q3 2020 | $33,943,000 | -1.3% | 619,393 | -4.7% | 1.88% | -3.3% |
| Q2 2020 | $34,381,000 | -3.4% | 650,051 | -18.4% | 1.95% | -9.9% |
| Q1 2020 | $35,580,000 | -35.8% | 796,682 | -28.3% | 2.16% | +10.0% |
| Q4 2019 | $55,434,000 | -2.5% | 1,111,798 | -12.8% | 1.97% | -9.5% |
| Q3 2019 | $56,855,000 | +4.6% | 1,275,623 | -3.1% | 2.17% | +10.3% |
| Q2 2019 | $54,362,000 | +1.6% | 1,316,906 | -0.5% | 1.97% | -0.7% |
| Q1 2019 | $53,504,000 | +2.4% | 1,323,368 | -3.8% | 1.98% | -2.8% |
| Q4 2018 | $52,260,000 | -10.4% | 1,375,987 | -6.7% | 2.04% | +9.8% |
| Q3 2018 | $58,339,000 | +9.2% | 1,474,322 | -3.1% | 1.86% | +4.7% |
| Q2 2018 | $53,416,000 | -3.9% | 1,521,389 | -4.3% | 1.77% | -3.9% |
| Q1 2018 | $55,589,000 | +5.1% | 1,589,632 | +4.2% | 1.84% | +5.4% |
| Q4 2017 | $52,915,000 | +4.2% | 1,524,917 | +1.7% | 1.75% | +0.2% |
| Q3 2017 | $50,787,000 | +6.6% | 1,499,012 | +7.2% | 1.74% | +2.2% |
| Q2 2017 | $47,664,000 | +10.3% | 1,398,177 | +0.7% | 1.71% | +8.6% |
| Q1 2017 | $43,223,000 | +23.0% | 1,388,017 | +7.9% | 1.57% | +20.8% |
| Q4 2016 | $35,147,000 | -10.8% | 1,286,487 | +7.3% | 1.30% | -15.7% |
| Q3 2016 | $39,398,000 | +10.4% | 1,198,972 | +1.4% | 1.54% | +6.0% |
| Q2 2016 | $35,701,000 | – | 1,182,550 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |